CorMedix (CRMD) EBITDA Margin (2013 - 2025)

CorMedix's (CRMD) quarterly EBITDA Margin came in at 0.07% in Q4 2025, down 7.0% year-on-year from 0.07% in Q4 2024, and down 939.84% quarter-over-quarter from 0.01% in Q3 2025.

CorMedix (CRMD) EBITDA Margin (2013 - 2025) Analysis & Trends

CorMedix has disclosed EBITDA Margin across 12 years of filings, most recently posting 0.07% for Q4 2025.

  • EBITDA Margin for Q4 2025 came in at 0.07%, down 7.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.03% (down 2.0% YoY), and the FY2025 annual result was 0.03%, down 2.0% from the prior year.
  • EBITDA Margin came in at 0.07% for Q4 2025 at CorMedix, down from 0.01% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 0.28% in Q2 2024 to a low of 100446.94% in Q3 2022.
  • The 4-year median for EBITDA Margin is 8180.42% (2021), against an average of 23831.51%.
  • Peak annual rise in EBITDA Margin reached 2072558 bps in 2022, while the deepest fall reached 8442570 bps in 2022.
  • CorMedix's EBITDA Margin stood at 13829.39% in 2021, then plunged by 99 bps to 27513.23% in 2022, then jumped by 100 bps to 0.01% in 2024, then tumbled by 1137 bps to 0.07% in 2025.
  • The last three EBITDA Margin figures came in at 0.07% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 38.10%
9 Abivax 91.71 Bn 91.71 Bn - -
10 CorMedix 631,378.03 -154.57 Mn 107.31 Mn -0.07%

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.07%
Sep 30, 2025 0.01%
Jun 30, 2025 -0.01%
Mar 31, 2025 -0.02%
Dec 31, 2024 0.01%
Sep 30, 2024 0.03%
Jun 30, 2024 0.28%
Dec 31, 2022 -27,513.23%
Sep 30, 2022 -100,446.94%
Jun 30, 2022 -35,831.37%
Mar 31, 2022 -92,606.12%
Dec 31, 2021 -13,829.39%
Sep 30, 2021 -22,508.52%
Jun 30, 2021 -56,556.95%
Mar 31, 2021 -8,180.42%
Dec 31, 2020 -10,921.13%
Sep 30, 2020 -7,102.43%
Jun 30, 2020 -22,912.91%
Mar 31, 2020 -7,513.55%
Dec 31, 2019 -21,425.98%